[ad_1] This news release contains forward-looking statements. For a description of the related risk factors and assumptions, please see the section entitled “Caution Concerning Forward-Looking Statements” later in this news release. MONTRÉAL, Feb. 12, 2025 […]
Trending Stories
Accuride Announces Confirmation of Plan of Reorganization
[ad_1] Court approves plan to equitize over 85% of the Company’s debt and establish a healthy, robust capital structure Accuride expects to emerge from Chapter 11 in the coming weeks as a North American wheel […]
Chroma Early Learning Academy Announces 12th Metro Atlanta Location in Canton, GA
[ad_1] ALPHARETTA, Ga., Feb. 12, 2025 /PRNewswire/ — Chroma Early Learning Academy, a leading provider of high-quality early childhood education, is proud to announce the opening of its 12th location in the Metro Atlanta area […]
MimiVax Announces Positive Interim Analysis in Ongoing SurVaxM Clinical Trial
[ad_1] Highlights: Ongoing clinical trial of SurVaxM in glioblastoma [SURVIVE] has successfully progressed following an interim analysis of trial data The clinical trial is designed to evaluate the safety, efficacy, and overall benefit of SurVaxM […]
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit
[ad_1] NEW YORK, Feb. 12, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between November 2, 2022 and December 19, 2024, […]
